Inventor
MATES SHARON
US39 patents
⚠️ This page may combine multiple inventors who share the name “MATES SHARON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTRA CELLULAR THERAPIES INC
32 patentsUS9428506B2Aug 30, 2016
Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
INTRA CELLULAR THERAPIES INC82 citations99
US11124514B2Sep 21, 2021
Compositions and methods
INTRA CELLULAR THERAPIES INC40 citations98
US11053245B2Jul 6, 2021
Methods
INTRA CELLULAR THERAPIES INC40 citations98
US11026951B2Jun 8, 2021
Methods of treating bipolar disorder
INTRA CELLULAR THERAPIES INC38 citations98
US10960009B2Mar 30, 2021
Methods of treating schizophrenia and depression
INTRA CELLULAR THERAPIES INC39 citations98
US10960010B2Mar 30, 2021
Pharmaceutical compositions for sustained or delayed release
INTRA CELLULAR THERAPIES INC38 citations98
US10899762B2Jan 26, 2021
Organic compounds
INTRA CELLULAR THERAPIES INC29 citations98
US10597394B2Mar 24, 2020
Organic compounds
INTRA CELLULAR THERAPIES INC30 citations98
US10322134B2Jun 18, 2019
Methods
INTRA CELLULAR THERAPIES INC49 citations98
US10245260B2Apr 2, 2019
Organic compounds
INTRA CELLULAR THERAPIES INC38 citations98
US10077267B2Sep 18, 2018
Organic compounds
INTRA CELLULAR THERAPIES INC69 citations98
US9956227B2May 1, 2018
Method for the treatment of residual symptoms of schizophrenia
INTRA CELLULAR THERAPIES INC78 citations98
US9745300B2Aug 29, 2017
Organic compounds
INTRA CELLULAR THERAPIES INC82 citations98
US9616061B2Apr 11, 2017
Methods and compositions for sleep disorders and other disorders
INTRA CELLULAR THERAPIES INC93 citations98
US9371324B2Jun 21, 2016
Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
INTRA CELLULAR THERAPIES INC90 citations98
US9168258B2Oct 27, 2015
Methods and compositions for sleep disorders and other disorders
INTRA CELLULAR THERAPIES INC106 citations98
US10702522B2Jul 7, 2020
Methods and compositions for sleep disorders and other disorders
INTRA CELLULAR THERAPIES INC40 citations97
US10117867B2Nov 6, 2018
Methods and compositions for sleep disorders and other disorders
INTRA CELLULAR THERAPIES INC57 citations97
US11560382B2Jan 24, 2023
Organic compounds
INTRA CELLULAR THERAPIES INC17 citations95
US11958852B2Apr 16, 2024
Compounds and methods
INTRA CELLULAR THERAPIES INC11 citations94
US11427587B2Aug 30, 2022
Organic compounds
INTRA CELLULAR THERAPIES INC31 citations94
US11376249B2Jul 5, 2022
Organic compounds
INTRA CELLULAR THERAPIES INC29 citations94
US10799500B2Oct 13, 2020
Organic compounds
INTRA CELLULAR THERAPIES INC28 citations94
USRE48839EDec 7, 2021
Methods and compositions for sleep disorders and other disorders
INTRA CELLULAR THERAPIES INC21 citations93
US12090155B2Sep 17, 2024
Methods
INTRA CELLULAR THERAPIES INC13 citations86
US11844757B2Dec 19, 2023
Organic compounds
INTRA CELLULAR THERAPIES INC10 citations86
US11773095B2Oct 3, 2023
Organic compounds
INTRA CELLULAR THERAPIES INC9 citations86
US12173004B2Dec 24, 2024
Pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugs
INTRA CELLULAR THERAPIES INC1 citations73
US12269825B2Apr 8, 2025
Organic compounds
INTRA CELLULAR THERAPIES INC0 citations63
US12565499B2Mar 3, 2026
Compounds and methods
INTRA CELLULAR THERAPIES INC0 citations62
US12440489B2Oct 14, 2025
Organic compounds
INTRA CELLULAR THERAPIES INC0 citations62
US10238660B2Mar 26, 2019
Organic compounds
INTRA CELLULAR THERAPIES INC0 citations51
MATES SHARON
3 patentsUS8993572B2Mar 31, 2015
Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives
MATES SHARON112 citations98
US8598119B2Dec 3, 2013
Methods and compositions for sleep disorders and other disorders
MATES SHARON138 citations98
US9198924B2Dec 1, 2015
Organic compounds
MATES SHARON24 citations91